These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23688060)

  • 1. Rate of progression of CT-quantified emphysema in male current and ex-smokers: a follow-up study.
    Mohamed Hoesein FA; Zanen P; de Jong PA; van Ginneken B; Boezen HM; Groen HJ; Oudkerk M; de Koning HJ; Postma DS; Lammers JW
    Respir Res; 2013 May; 14(1):55. PubMed ID: 23688060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study.
    Coxson HO; Dirksen A; Edwards LD; Yates JC; Agusti A; Bakke P; Calverley PM; Celli B; Crim C; Duvoix A; Fauerbach PN; Lomas DA; Macnee W; Mayer RJ; Miller BE; Müller NL; Rennard SI; Silverman EK; Tal-Singer R; Wouters EF; Vestbo J;
    Lancet Respir Med; 2013 Apr; 1(2):129-36. PubMed ID: 24429093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year Progression of Emphysema and Air Trapping at CT in Smokers with and Those without Chronic Obstructive Pulmonary Disease: Results from the COPDGene Study.
    Pompe E; Strand M; van Rikxoort EM; Hoffman EA; Barr RG; Charbonnier JP; Humphries S; Han MK; Hokanson JE; Make BJ; Regan EA; Silverman EK; Crapo JD; Lynch DA;
    Radiology; 2020 Apr; 295(1):218-226. PubMed ID: 32013794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emphysema distribution and annual changes in pulmonary function in male patients with chronic obstructive pulmonary disease.
    Tanabe N; Muro S; Tanaka S; Sato S; Oguma T; Kiyokawa H; Takahashi T; Kinose D; Hoshino Y; Kubo T; Ogawa E; Hirai T; Mishima M
    Respir Res; 2012 Apr; 13(1):31. PubMed ID: 22512922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-quantified emphysema in male heavy smokers: association with lung function decline.
    Mohamed Hoesein FA; de Hoop B; Zanen P; Gietema H; Kruitwagen CL; van Ginneken B; Isgum I; Mol C; van Klaveren RJ; Dijkstra AE; Groen HJ; Boezen HM; Postma DS; Prokop M; Lammers JW
    Thorax; 2011 Sep; 66(9):782-7. PubMed ID: 21474499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the transfer coefficient of the lung for carbon monoxide with emphysema progression in male smokers.
    Mohamed Hoesein FA; Zanen P; van Ginneken B; van Klaveren RJ; Lammers JW
    Eur Respir J; 2011 Nov; 38(5):1012-8. PubMed ID: 21565924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung function decline in male heavy smokers relates to baseline airflow obstruction severity.
    Mohamed Hoesein FAA; Zanen P; Boezen HM; Groen HJM; van Ginneken B; de Jong PA; Postma DS; Lammers JJ
    Chest; 2012 Dec; 142(6):1530-1538. PubMed ID: 22722231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of vascular alteration in smokers by quantitative computed tomography measurements.
    Yu N; Yuan H; Duan HF; Ma JC; Ma GM; Guo YM; Wu F
    Medicine (Baltimore); 2019 Feb; 98(7):e14438. PubMed ID: 30762753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent airway inflammation and emphysema progression on CT scan in ex-smokers observed for 4 years.
    Miller M; Cho JY; Pham A; Friedman PJ; Ramsdell J; Broide DH
    Chest; 2011 Jun; 139(6):1380-1387. PubMed ID: 20966041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Immunological Factors in Emphysema Progression. Five-Year Prospective Longitudinal Exacerbation Study of Chronic Obstructive Pulmonary Disease (LES-COPD).
    Bhavani S; Tsai CL; Perusich S; Hesselbacher S; Coxson H; Pandit L; Corry DB; Kheradmand F
    Am J Respir Crit Care Med; 2015 Nov; 192(10):1171-8. PubMed ID: 26241705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of chronic obstructive pulmonary disease in lung cancer screening Computed Tomography scans: independent contribution of emphysema, air trapping and bronchial wall thickening.
    Mets OM; Schmidt M; Buckens CF; Gondrie MJ; Isgum I; Oudkerk M; Vliegenthart R; de Koning HJ; van der Aalst CM; Prokop M; Lammers JW; Zanen P; Mohamed Hoesein FA; Mali WP; van Ginneken B; van Rikxoort EM; de Jong PA
    Respir Res; 2013 May; 14(1):59. PubMed ID: 23711184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and progression of combined pulmonary fibrosis and emphysema in asymptomatic smokers: A case-control study.
    Chae KJ; Jin GY; Han YM; Kim YS; Chon SB; Lee YS; Kwon KS; Choi HM; Lynch D
    Eur Radiol; 2015 Aug; 25(8):2326-34. PubMed ID: 25680720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and correlates of pulmonary emphysema in smokers and former smokers. A densitometric study of participants in the ITALUNG trial.
    Camiciottoli G; Cavigli E; Grassi L; Diciotti S; Orlandi I; Zappa M; Picozzi G; Pegna AL; Paci E; Falaschi F; Mascalchi M
    Eur Radiol; 2009 Jan; 19(1):58-66. PubMed ID: 18690451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of smoking cessation on quantitative computed tomography in smokers at risk in a lung cancer screening population.
    Jobst BJ; Weinheimer O; Trauth M; Becker N; Motsch E; Groß ML; Tremper J; Delorme S; Eigentopf A; Eichinger M; Kauczor HU; Wielpütz MO
    Eur Radiol; 2018 Feb; 28(2):807-815. PubMed ID: 28884215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed tomography-quantified emphysema distribution is associated with lung function decline.
    Mohamed Hoesein FA; van Rikxoort E; van Ginneken B; de Jong PA; Prokop M; Lammers JW; Zanen P
    Eur Respir J; 2012 Oct; 40(4):844-50. PubMed ID: 22323577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early smoking-induced lung lesions in asymptomatic subjects. Correlations between high resolution dynamic CT and pulmonary function testing.
    Spaggiari E; Zompatori M; Verduri A; Chetta A; Bnà C; Ormitti F; Sverzellati N; Rabaiotti E
    Radiol Med; 2005; 109(1-2):27-39. PubMed ID: 15729184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual Emphysema at Chest CT in GOLD Stage 0 Cigarette Smokers Predicts Disease Progression: Results from the COPDGene Study.
    Oh AS; Strand M; Pratte K; Regan EA; Humphries S; Crapo JD; Lynch DA;
    Radiology; 2020 Sep; 296(3):641-649. PubMed ID: 32633676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computed tomography density histogram analysis to evaluate pulmonary emphysema in ex-smokers.
    Owrangi AM; Etemad-Rezai R; McCormack DG; Cunningham IA; Parraga G
    Acad Radiol; 2013 May; 20(5):537-45. PubMed ID: 23570935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT-based Visual Classification of Emphysema: Association with Mortality in the COPDGene Study.
    Lynch DA; Moore CM; Wilson C; Nevrekar D; Jennermann T; Humphries SM; Austin JHM; Grenier PA; Kauczor HU; Han MK; Regan EA; Make BJ; Bowler RP; Beaty TH; Curran-Everett D; Hokanson JE; Curtis JL; Silverman EK; Crapo JD;
    Radiology; 2018 Sep; 288(3):859-866. PubMed ID: 29762095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in FEV
    Hiller AM; Piitulainen E; Jehpsson L; Tanash H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.